Evidence is strengthening for the morphological evaluation of tumor infiltrating lymphocytes
(TILs) in breast cancer. Herein, the concepts for TILs assessment are laid out by pathologists …

The interest in tumor-infiltrating lymphocytes (TILs) as a prognostic biomarker in breast
cancer has grown in recent years. Biomarkers must undergo comprehensive evaluation in …

Morphological evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer is gaining
momentum as evidence strengthens the clinical relevance of this immunological biomarker …

Assessment of tumor-infiltrating lymphocytes (TILs) in histopathologic specimens can
provide important prognostic information in diverse solid tumor types, and may also be of …

Tumor-infiltrating lymphocytes (TILs) influence tumor prognosis and the chemotherapeutic
response. Here, we quantified the clinical relevance of TILs, including the effect of TILs on …

Simple Summary Tumor-infiltrating lymphocytes (TILs) are immune cells that can be
involved in the anti-tumor response and are presently viewed as a promising, inexpensive …

In 2014, we described a method to quantify percentage of tumor-infiltrating lymphocytes
(TILs) on hematoxylin and eosin-stained slides of breast cancer samples using light …

The recent success of the immune checkpoint blockade in cancer immunotherapy has
modified the treatment algorithms in a variety of aggressive neoplastic diseases …

Background The presence of tumor-infiltrating lymphocytes (TILs) in breast tumors is
prognostic and predictive, suggesting that TILs may be an important biomarker. Recently, an …

Background Tumor-infiltrating lymphocyte (TIL) count in breast cancer carries prognostic
information and represents a potential predictive marker for emerging immunotherapies …